Cargando…

Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management

The most common form of congenital adrenal hyperplasia is 21-hydroxylase deficiency (21OHD), which in the classic (severe) form occurs in roughly 1:16 000 newborns worldwide. Lifelong treatment consists of replacing cortisol and aldosterone deficiencies, and supraphysiological dosing schedules are t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarafoglou, Kyriakie, Merke, Deborah P, Reisch, Nicole, Claahsen-van der Grinten, Hedi, Falhammar, Henrik, Auchus, Richard J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Mini-Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438890/ https://www.ncbi.nlm.nih.gov/pubmed/36950738 http://dx.doi.org/10.1210/clinem/dgad134

Ejemplares similares

Sexuality in Males With Congenital Adrenal Hyperplasia Resulting From 21-Hydroxylase Deficiency
por: Gehrmann, Katharina, et al.
Publicado: (2019)

SUN-360 Multi-Steroid Panels to Replace Dynamic Testing for the Diagnosis of Nonclassic 21-Hydroxylase Deficiency
por: Turcu, Adina, et al.
Publicado: (2019)

Quality of Life in Men With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Verhees, Myrthe J. M., et al.
Publicado: (2021)

Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis
por: Nowotny, Hanna, et al.
Publicado: (2021)

24-Hour Profiles of 11-Oxygenated C(19) Steroids and Δ(5)-Steroid Sulfates during Oral and Continuous Subcutaneous Glucocorticoids in 21-Hydroxylase Deficiency
por: Turcu, Adina F., et al.
Publicado: (2021)

Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia
por: Auchus, Richard J, et al.
Publicado: (2021)

11-Oxygenated Androgens Are Biomarkers of Adrenal Volume and Testicular Adrenal Rest Tumors in 21-Hydroxylase Deficiency
por: Turcu, Adina F., et al.
Publicado: (2017)

Growth-Related Characteristics of Patients <18 Years of Age with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency (21OHD): Real World Evidence from the I-CAH Registry
por: Farrar, Mallory, et al.
Publicado: (2021)

Changes in Adrenal and Gonadal Androgens After 14-Day Treatment With CRF1 Receptor Antagonist, Crinecerfont (NBI-74788), in Men With Classic 21-Hydroxylase Deficiency
por: He, Xin, et al.
Publicado: (2021)

Health status in 1040 adults with disorders of sex development (DSD): a European multicenter study
por: Falhammar, Henrik, et al.
Publicado: (2018)

Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe
por: Nowotny, Hanna, et al.
Publicado: (2022)

Optimizing the Timing of Highest Hydrocortisone Dose in Children and Adolescents With 21-Hydroxylase Deficiency
por: Schröder, Mariska A M, et al.
Publicado: (2021)

Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Kocova, Mirjana, et al.
Publicado: (2022)

Molecular genetic testing of congenital adrenal hyperplasia due to 21-hydroxylase deficiency should include CAH-X chimeras
por: Lao, Qizong, et al.
Publicado: (2021)

Prenatal Diagnosis and Treatment of Steroid 21-Hydroxylase Deficiency
por: Tajima, Toshihiro, et al.
Publicado: (2008)

Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Zetterström, Rolf H., et al.
Publicado: (2020)

Bacterial steroid hydroxylases: enzyme classes, their functions and comparison of their catalytic mechanisms
por: Szaleniec, Maciej, et al.
Publicado: (2018)

Tildacerfont for the Treatment of Patients With Classic Congenital Adrenal Hyperplasia: Results From a 12-Week Phase 2 Clinical Trial in Adults With Classic CAH
por: Auchus, Richard Joseph, et al.
Publicado: (2021)

A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency
por: Speiser, Phyllis W., et al.
Publicado: (2010)

Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Kocova, Mirjana, et al.
Publicado: (2020)

Long-Term Results of Surgical Treatment and Patient-Reported Outcomes in Congenital Adrenal Hyperplasia—A Multicenter European Registry Study
por: Krege, Susanne, et al.
Publicado: (2022)

Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Espinosa Reyes, Tania Mayvel, et al.
Publicado: (2020)

Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency: A Practical Approach
por: Arriba, María, et al.
Publicado: (2022)

Pregnancy outcomes in in vitro fertilization in 17-alpha-hydroxylase deficiency
por: van Oosbree, Annika, et al.
Publicado: (2023)

SAT286 Effect of Tildacerfont On Gonadotropins And Testicular Steroidogenesis In Men With Classic 21-hydroxylase Deficiency
por: Will Charlton, R, et al.
Publicado: (2023)

Increased Risk of Autoimmune Disorders in 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study
por: Falhammar, Henrik, et al.
Publicado: (2019)

Genotype-Phenotype Correlation in Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency in Cuba
por: Espinosa Reyes, Tania Mayvel, et al.
Publicado: (2021)

Body Image and Quality of Life in Women with Congenital Adrenal Hyperplasia
por: Tschaidse, Lea, et al.
Publicado: (2022)

Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia
por: Righi, Beatrice, et al.
Publicado: (2023)

Novel treatments for congenital adrenal hyperplasia
por: Schröder, Mariska A. M., et al.
Publicado: (2022)

Assay of steroids by liquid chromatography–tandem mass spectrometry in monitoring 21-hydroxylase deficiency
por: Dahl, Sandra R, et al.
Publicado: (2018)

Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies
por: Sarafoglou, Kyriakie, et al.
Publicado: (2021)

Socioeconomic status in patients with Turner syndrome
por: Noordman, Iris D., et al.
Publicado: (2021)

ODP046 Initial Lessons from a Prescreening Protocol to Identify Participants with Classic CAH Potentially Eligible for Gene Therapy Treatment with BBP-631, an Adeno-associated Virus (AAV) Serotype 5-Based Recombinant Vector Encoding the Human CYP21A2 Gene
por: Bharucha, Kamal, et al.
Publicado: (2022)

rhIGF-1 Therapy for Growth Failure and IGF-1 Deficiency in Congenital Disorder of Glycosylation Ia (PMM2 Deficiency)
por: Miller, Bradley S., et al.
Publicado: (2013)

Steroid 21-hydroxylase gene variants and late-life depression
por: Ancelin, Marie-Laure, et al.
Publicado: (2021)

Primary Amenorrhea with Apparently Absent Uterus: A Report of Three Cases
por: Porsius, Eva, et al.
Publicado: (2022)

Best Practice for Identification of Classical 21-Hydroxylase Deficiency Should Include 21 Deoxycortisol Analysis with Appropriate Isomeric Steroid Separation
por: Greaves, Ronda F., et al.
Publicado: (2023)

Metastatic Pheochromocytomas and Abdominal Paragangliomas
por: Granberg, Dan, et al.
Publicado: (2021)

21-Hydroxylase Deficiency: Newborn Screening in Iran?
por: Mahdieh, Nejat, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ta3k1vtaja4hk9l0d2i9tde952